Dual SPECT of dopamine system using [99mTc]TRODAT-1 and [123I]IBZM in normal and 6-OHDA-lesioned formosan rock monkeys

Nucl Med Biol. 2002 Jul;29(5):561-7. doi: 10.1016/s0969-8051(02)00303-7.

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by a severe loss of the dopaminergic neurons in the substantia nigra pars compacta. In this study, we evaluated pre- and post-synaptic binding sites of the dopamine system in three normal and one parkinsonian monkeys using simultaneous [99mTc]TRODAT-1 and [123I]IBZM imaging. The parkinsonian monkey was induced by injecting 6-hydroxydopamine (6-OHDA) bilaterally into the medial forebrain bundle under MRI guidance. [99mTc]TRODAT-1 (targeting dopamine transporters) and [123I]IBZM (targeting D(2)/D(3) receptors) were administered almost simultaneously and the SPECT images were acquired over 4 h using a dual-headed gamma camera equipped with ultra-high resolution fan-beam collimators. Data were obtained using energy window of 15% centered on 140 keV for 99mTc in conjunction with 10% asymmetric energy window in a lower bound at 159 keV for 123I. Single SPECT studies of [99mTc]TRODAT-1 and [123I]IBZM were also performed. We found a comparable image quality and uptake ratios between single- and dual-isotope studies. There are higher TRODAT-1 uptakes in the control monkeys than the 6-OHDA-lesioned monkey. The uptake of [123I] IBZM showed no significant difference between controls and 6-OHDA-lesioned monkey. Our results suggest that dual isotope imaging using [99mTc]TRODAT-1 and [123I]IBZM may be a useful means in evaluating the changes of both pre- and post-synaptic dopamine system in a primate model of parkinsonism.

Publication types

  • Comparative Study
  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Benzamides / pharmacokinetics*
  • Brain / diagnostic imaging*
  • Brain / metabolism*
  • Dopamine / metabolism
  • Macaca
  • Organotechnetium Compounds / pharmacokinetics*
  • Oxidopamine / administration & dosage
  • Parkinsonian Disorders / chemically induced
  • Parkinsonian Disorders / diagnostic imaging
  • Parkinsonian Disorders / metabolism*
  • Predictive Value of Tests
  • Pyrrolidines / pharmacokinetics*
  • Radiopharmaceuticals / pharmacokinetics
  • Reference Values
  • Sensitivity and Specificity
  • Tissue Distribution
  • Tomography, Emission-Computed, Single-Photon / methods*
  • Tropanes / pharmacokinetics*

Substances

  • Benzamides
  • Organotechnetium Compounds
  • Pyrrolidines
  • Radiopharmaceuticals
  • Tropanes
  • technetium Tc 99m TRODAT-1
  • 3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide
  • Oxidopamine
  • Dopamine